Literature DB >> 8990236

Short-term and long-term variability of plasma homocysteine measurement.

U C Garg1, Z J Zheng, A R Folsom, Y S Moyer, M Y Tsai, P McGovern, J H Eckfeldt.   

Abstract

Within-person and methodological variability of a given analyte are important elements in determining whether an individual has altered concentrations of that analyte. We report the short-term (1 month) within-person, between-person, and methodological variability of plasma homocysteine in 20 healthy participants from whom samples were drawn weekly for 4 weeks. The short-term between-person variance was high, whereas within-person and methodological variances were relatively very low, giving a high reliability coefficient (R) for homocysteine (R = 0.94). The long-term (30 months) reliability coefficient was 0.65, but was greatly influenced by an outlier (R = 0.82 with the outlier excluded). The data suggest that an individual's plasma homocysteine concentration is relatively constant over at least 1 month, and a single measurement characterizes the average concentration reasonably well.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990236

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  14 in total

1.  Plasma homocysteine and risk of mild cognitive impairment.

Authors:  Christiane Reitz; Ming-Xin Tang; Joshua Miller; Ralph Green; José A Luchsinger
Journal:  Dement Geriatr Cogn Disord       Date:  2008-12-16       Impact factor: 2.959

2.  Intraindividual variation in one-carbon metabolism plasma biomarkers.

Authors:  Elizabeth L Cope; Martha J Shrubsole; Sarah S Cohen; Qiuyin Cai; Jie Wu; Per Magne Ueland; Øivind Midttun; Jennifer S Sonderman; William J Blot; Lisa B Signorello
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-15       Impact factor: 4.254

Review 3.  ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.

Authors:  R A Still; I F McDowell
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

4.  Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes.

Authors:  M K Al-Obaidi; P J Stubbs; R Amersey; M I Noble
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

5.  Relationships among biomarkers of one-carbon metabolism.

Authors:  Will D King; Vikki Ho; Linda Dodds; Sherry L Perkins; R Ian Casson; Thomas E Massey
Journal:  Mol Biol Rep       Date:  2012-04-24       Impact factor: 2.316

Review 6.  Diagnosis and treatment of hyperhomocysteinemia.

Authors:  M E Keebler; C De Souza ; V Fonseca
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

7.  Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations.

Authors:  M R Malinow; P B Duell; M A Williams; W D Kruger; A A Evans; P H Anderson; P C Block; D L Hess; B M Upson; E E Graf; A Irvin-Jones; L Wang
Journal:  Lipids       Date:  2001       Impact factor: 1.880

8.  The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism.

Authors:  Emily Joachim; Neil A Goldenberg; Timothy J Bernard; Jennifer Armstrong-Wells; Sally Stabler; Marilyn J Manco-Johnson
Journal:  Thromb Res       Date:  2013-07-16       Impact factor: 3.944

9.  Standardization of homocysteine on HPLC using DTT as reductant.

Authors:  Tester F Ashavaid; Farah F Eghlim; Kavita K Shalia; Kappiareth G Nair
Journal:  Indian J Clin Biochem       Date:  2003-07

10.  Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients.

Authors:  Oivind Midttun; Mary K Townsend; Ottar Nygård; Shelley S Tworoger; Paul Brennan; Mattias Johansson; Per Magne Ueland
Journal:  J Nutr       Date:  2014-03-19       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.